RPS6KB1 and breast neoplasm: We have also recently shown that S6K2 is amplified and overexpressed in breast tumours, and the results indicated that S6K1 and S6K2 amplification may have prognostic significance independent of the neighbouring oncogenes ERBB2 and CCND1[8].